Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nantes
Clinical trial register · France

Clinical Trials in Nantes, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 2821 Lyon 1392 Bordeaux 1389 Marseille 1285 Lille 1282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Nantes University Hospital176 Janssen Research & Development, LLC35 AstraZeneca27 Novartis Pharmaceuticals25 Sanofi17
Site location
Paris2821 Lyon1392 Bordeaux1389 Marseille1285 Lille1282
All 804 locations
Target enrolment
to

Trials with a site in Nantes

906 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Active, closed
BeOne Medicines
Phase 3
652
Bordeaux, ClermontFerrand, Esseylesnancy, Le Mans, Lille, Lyon, Nantes, Paris
2023-11-11
Recruiting
University Hospital, Angers
Not applicable
200
Angers, Brest, Nantes, Rennes, Tours
2023-11-09
Recruiting
Nantes University Hospital
Observational
106
Nantes
2023-11-08
Recruiting
Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.
NCT06023706Coccyx Disorder, Neuropathic Pain, Coccygodynia
DrugCapsaicin
Nantes University Hospital
Phase 3
188
Brest, La Roche-sur-Yon, Nantes, Paris, Rouen
2023-11-08
Active, closed
Novartis Pharmaceuticals
Phase 1
33
Dijon, Clermont-Ferrand, Lyon, Nantes, Saint-Herblain, Vandœuvre-lès-Nancy
2023-11-07
Recruiting
Nantes University Hospital
Not applicable
340
Nantes
2023-11-07
Active, closed
TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565Hepatocellular Carcinoma
Boston Scientific Corporation
Phase 2
100
Rennes, Clichy, Grenoble, Clermont-Ferrand, Créteil, Lille, Montpellier, Nantes
2023-11-03
By invitation
Edgewise Therapeutics, Inc.
Phase 2
260
Marseille, Nantes, Nice, Paris
2023-11-02
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Lille, Poitiers, Nantes, Paris
2023-11-01
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
170
Dijon, Bourdeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2023-10-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Bron, Grenoble, Angers, Nantes, Marseille, Bobigny, Brest, Dijon
2023-10-25
Recruiting
University Hospital, Bordeaux
Not applicable
1,307
Angers, Bordeaux, Cabestany, Caen, Créteil, Marseille, Mont-de-Marsan, Nantes
2023-10-23
Recruiting
Rennes University Hospital
Not applicable
150
Bordeaux, Caen, Clermont-Ferrand, Lille, Lyon, Nantes, Paris, Rennes
2023-10-23
Recruiting
Hoffmann-La Roche
Phase 3
182
Lille, Montpellier, Nantes, Paris
2023-10-22
Active, closed
Nantes University Hospital
Not applicable
60
Nantes
2023-10-20
Active, closed
Sanofi
Observational
150
Nantes
2023-10-20
Recruiting
Institut Cancerologie de l'Ouest
Phase 3
274
Angers, Bordeaux, Caen, Grenoble, Limoges, Lyon, Nantes, Nice
2023-10-20
Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
NCT05879757Multiple Myeloma, Secondary Immunodeficiency (SID)
Takeda
Observational
75
Salouël, Dijon, Nantes, Orléans, Pessac
2023-10-17
Active, closed
Celgene
Phase 3
79
Pessac, Marseille, Lille, Nantes, Pierre-Bénite, Créteil, Villejuif, Poitiers
2023-10-16
Recruiting
Effectiveness of a Joint General Practitioner-Pharmacist Intervention on Benzodiazepine Deprescribing in the Elderly
NCT05765656Primary Care, Health Plan Implementation, Benzodiazepine Dependence, Elderly
Nantes University Hospital
Not applicable
400
Nantes
2023-10-16
Recruiting
AbbVie
Phase 3
1,500
Nice, Rennes, Bordeaux, Toulouse, Reims, Nantes, Lyon, Brest
2023-10-11
Active, closed
Stichting European Myeloma Network
Phase 3
759
Lille, Lyon, Nantes, Poitiers, Saint-Louis, Toulouse
2023-10-10
Recruiting
NAC- NAFLD And Cushing
NCT05881005Cushing Syndrome, Fatty Liver Disease
University Hospital, Angers
Not applicable
100
Angers, Bordeaux, Brest, Grenoble, Lille, Nantes, Vandœuvre-lès-Nancy
2023-09-28
Recruiting
University Hospital, Bordeaux
Not applicable
192
Angers, Bordeaux, Caen, Le Kremlin-Bicêtre, Marseille, Nantes
2023-09-19
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Lille, Lyon, Marseille, Montpellier, Nantes, Pessac, Rennes, Rouen
2023-09-18
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Bron, Grenoble, Nantes, Marseille, Angers, Bobigny, Brest, Dijon
2023-09-14
Recruiting
Nantes University Hospital
Phase 2
302
Nantes, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2023-09-14
Active, closed
Hoffmann-La Roche
Phase 3
687
Caen, Lille, Limoges, Marseille, Nantes, Paris, Reims, Valence
2023-09-14
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
DrugsCyclophosphamid·Rituximab
Alentis Therapeutics AG
Phase 2
80
Boulogne-sur-Mer, Bordeaux, Brest, La Tronche, Marseille, Nantes, Nîmes, Paris
2023-09-07
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille, Massy, Nantes, Paris
2023-09-05
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Clermont-Ferrand, La Tronche, Lille, Montpellier, Nantes, Paris, Pessac, Rennes
2023-09-01
Active, closed
Environmental Exposures and Sudden Unexpected Infant Death
NCT06708793Sudden Unexpected Infant Death, Air Pollution, Pesticides
Nantes University Hospital
Observational
100
Nantes
2023-09-01
By invitation
Disc Medicine, Inc
Phase 2/3
230
Nantes, Paris
2023-08-31
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
DrugOlverembatinib
Ascentage Pharma Group Inc.
Phase 3
350
Le Chesnay, Lyon, Nantes, Nice, Pessac, Pierre-Bénite, Poitiers, Toulouse
2023-08-31
Active, closed
RegenLab France SAS
Not applicable
280
Dijon, Corbeil-Essonnes, Créteil, La Roche-sur-Yon, Limoges, Lyon, Montpellier, Nantes
2023-08-21
Recruiting
Centre Leon Berard
Not applicable
166
Nantes, Lyon, Angers, Bordeaux, Chambray-lès-Tours, Clermont-Ferrand, Dijon, Lille
2023-08-03
Recruiting
GlaxoSmithKline
Phase 3
892
Lyon, Marseille, Nantes, Paris, Pessac, Rennes, Rouen, Saint-Priest-en-Jarez
2023-08-01
Recruiting
Nantes University Hospital
Not applicable
40
Nantes
2023-07-24
Active, closed
Hoffmann-La Roche
Phase 2
21
Nantes, Neuilly-sur-Seine, Vandœuvre-lès-Nancy
2023-07-24
Recruiting
University Hospital, Clermont-Ferrand
Phase 2
600
Bordeaux, Clermont-Ferrand, La Roche-sur-Yon, Nantes
2023-07-21
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 3
90
Brest, Grenoble, Lille, Limoges, Lyon, Marseille, Nancy, Nantes
2023-06-29
Active, closed
Swedish Orphan Biovitrum
Observational
165
Nice, Pessac, Suresnes, Grenoble, Nantes, Vandœuvre-lès-Nancy, Lille, La Defense
2023-06-26
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Amiens, Caen, Créteil, La Roche-sur-Yon, Lille, Limoges, Nantes, Paris
2023-06-22
Active, closed
AbbVie
Phase 3
1,328
Nice, Bordeaux, Reims, Nantes, Lyon, Antony
2023-06-21
Recruiting
CSL Behring
Observational
500
Brest, Nantes, Vandœuvre-lès-Nancy
2023-06-15
Active, closed
Alfasigma S.p.A.
Observational
509
Amiens, Besançon, Clichy, Grenoble, Lille, Montpellier, Nancy, Nantes
2023-06-12
Active, closed
AbbVie
Phase 1
135
Bordeaux, Montpellier, Lille, Nantes, Villejuif, Paris
2023-06-09
Active, closed
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
NCT05778071Chronic Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases
Alexion Pharmaceuticals, Inc.
Phase 3
165
Marseille, Nantes, Paris
2023-06-07
Recruiting
Hoffmann-La Roche
Phase 3
100
Marseille, Bordeaux, Caen, Dijon, Lyon, Montpellier, Nantes, Nîmes
2023-06-01
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Pessac, Nantes, Lille, Marseille, Paris
2023-05-31
Active, closed
Apellis Pharmaceuticals, Inc.
Phase 3
100
Bordeaux, Nantes
2023-05-29
Active, closed
Nantes University Hospital
Not applicable
60
Nantes
2023-05-17
Recruiting
University Hospital, Angers
Observational
120
Angers, Brest, Nantes, Poitiers, Rennes, Tours
2023-05-17
Recruiting
OPTImal Treatment of Sinus VENOSUS Defect
NCT05865119Sinus Venosus Defect, Congenital Heart Disease, Sinus Venosus Atrial Septum Defect
Centre Chirurgical Marie Lannelongue
Not applicable
60
Bordeaux, Bron, Clermont-Ferrand, Grenoble, Le Plessis-Robinson, Lille, Marseille, Nantes
2023-05-12
Active, closed
Novartis Pharmaceuticals
Phase 1
71
Grenoble, Nantes, Paris
2023-05-08
Active, closed
Servier Affaires Médicales
Phase 3
299
Lyon, Marseille, Montpellier, Nantes, Paris, Pessac, Poitiers
2023-05-03
Recruiting
Treatment of Intra-articular Fractures of the Mandibular Condyle
NCT04776473Intra-articular Fracture of the Mandibular Condyle
Assistance Publique - Hôpitaux de Paris
Not applicable
110
Angers, Annecy, Marseille, Nantes, Paris, Strasbourg, Toulouse
2023-05-03
Active, closed
UroMems SAS
Not applicable
6
Nantes, Paris
2023-05-02
Recruiting
University Hospital, Toulouse
Not applicable
296
Amiens, Bordeaux, Clermont-Ferrand, Lille, Nantes, Paris, Saint-Denis, Toulouse
2023-05-02
Recruiting
Intra-Cellular Therapies, Inc.
Phase 3
470
Douai, Nantes, Nîmes, Paris, Poitiers
2023-05-02
Recruiting
ANRS, Emerging Infectious Diseases
Phase 2
256
Bordeaux, Dijon, Lyon, Montpellier, Nantes, Paris, Reims, Toulouse
2023-04-27
Recruiting
University Hospital, Angers
Not applicable
50
Angers, Brest, Cholet, Créteil, Marseille, Nantes, Paris, Pessac
2023-04-24
By invitation
Sanofi
Phase 2
70
Nantes
2023-04-05
Active, closed
University Hospital, Strasbourg, France
Not applicable
200
Lyon, Nantes, Nice, Reims, Strasbourg, Marseille, Rennes, Saint-Herblain
2023-04-04
Active, closed
Sanofi
Phase 2
999
Créteil, Lille, Marseille, Nantes, Paris, Pierre-Bénite, Toulouse
2023-04-03
Recruiting
Nantes University Hospital
Observational
100
Nantes
2023-04-03
Active, closed
Bial R&D Investments, S.A.
Phase 2
237
Nantes, Nice, Nîmes, Paris, Rennes, Toulouse
2023-03-31
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Marseille, Nantes, Paris
2023-03-30
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Amiens, Caen, Grenoble, Le Mans, Lille, Montpellier, Nantes, Paris
2023-03-29
Recruiting
University Hospital, Brest
Not applicable
550
Amiens, Brest, Caen, Créteil, Nantes, Nice, Paris, Tours
2023-03-28
Active, closed
Boston Scientific Corporation
Observational
1,173
Grenoble, Lomme, Nantes, Neuilly, Saint-Denis, Toulouse
2023-03-24
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Bordeaux, Clermont-Ferrand, Grenoble, Limoges, Lyon, Nantes, Nîmes, Orléans
2023-03-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 4
480
Corbeil-Essonnes, Orsay, Clamart, Boulogne, Nantes, Lille, Paris, Meaux
2023-03-22
Recruiting
AbbVie
Phase 1
210
Marseille, Créteil, Nantes, Pierre-Bénite, Poitiers, Paris
2023-03-21
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 1/2
26
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nancy, Nantes, Paris
2023-03-15
Active, closed
University Hospital, Grenoble
Phase 1
43
Grenoble, Angers, Bordeaux, Marseille, Nantes, Paris, Reims, Toulouse
2023-03-15
Recruiting
Lumara Bio Oncologics GmbH
Phase 1/2
270
Clermont-Ferrand, Dijon, Grenoble, Lyon, Marseille, Nantes, Toulouse, Vandœuvre-lès-Nancy
2023-03-14
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
177
Lille, Marseille, Nantes, Nice, Rennes, Toulouse
2023-03-10
By invitation
Eli Lilly and Company
Phase 3
333
Romans-sur-Isère, Lille, Nantes, Toulouse
2023-03-09
Active, closed
Bristol-Myers Squibb
Phase 3
579
Toulouse, Chambray-lès-Tours, Lille, Nantes, Villejuif, Amiens, Bayonne, Bordeaux
2023-03-06
Recruiting
Eli Lilly and Company
Phase 3
595
Brest, Marseille, Nantes, Nice, Paris, Tours
2023-02-27
Recruiting
K36 Therapeutics, Inc.
Phase 1
165
Villeneuve-d'Ascq, Nantes, Poitiers, Toulouse
2023-02-22
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Bron, Le Kremlin-Bicêtre, Lille, Nantes
2023-02-13
Recruiting
Medtronic Cardiovascular
Not applicable
400
Toulouse, Bordeaux, Créteil, Marseille, Nantes, Rennes, Saint-Denis, Tours
2023-02-07
Recruiting
EDAP TMS S.A.
Observational
3,000
Aix-en-Provence, Besançon, Colmar, Lyon, Nantes
2023-02-01
Active, closed
Stryker Craniomaxillofacial
Observational
99
Toulouse, Paris, Nantes
2023-02-01
Recruiting
Tenaya Therapeutics
Observational
200
Bron, Nantes, Paris, Pessac
2023-01-31
Recruiting
Women Hypertensive and Young-Renal Denervation
NCT05563337Arterial Hypertension
University Hospital, Bordeaux
Not applicable
80
Bordeaux, Grenoble, Lille, Nantes, Paris, Toulouse
2023-01-31
Recruiting
University Hospital, Lille
Observational
356
Béthune, Boulogne-sur-Mer, Calais, Lens, Lille, Nantes, Roubaix, Rouen
2023-01-30
Active, closed
Bristol-Myers Squibb
Phase 3
516
Strasbourg, Nantes, Le Kremlin-Bicêtre, Tours
2023-01-12
Active, closed
Daiichi Sankyo
Phase 3
1,170
Avignon, Besançon, Bordeaux, France, Lyon, Marseille, Montpellier, Nantes
2023-01-11
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Créteil, Lille, Nantes, Nice
2022-12-30
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Lille, Marseille, Nantes, Paris, Rennes, Strasbourg, Toulouse, Villeurbanne
2022-12-23
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Avignon, Brest, Caen, Chambray-lès-Tours, Cholet, Contamine-sur-Arve, Lyon, Nantes
2022-12-16
Active, closed
Janssen Research & Development, LLC
Phase 3
213
Caen, Nantes, Paris, Pessac
2022-12-15
Recruiting
Pharming Technologies B.V.
Phase 2
180
Angers, Bordeaux, Lille, Nantes, Nice, Paris, Strasbourg
2022-12-13
Active, closed
Carmat SAS
Not applicable
104
Bron, Dijon, Le Plessis-Robinson, Lille, Montpellier, Nantes, Paris, Rennes
2022-12-12
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
80
Bordeaux, Marseille, Montpellier, Nantes, Nice, Nîmes, Paris, Toulouse
2022-12-07
By invitation
Ionis Pharmaceuticals, Inc.
Phase 3
1,400
Créteil, La Roche-sur-Yon, Marseille, Nantes, Pessac, Toulouse
2022-11-30
Recruiting
University Hospital, Montpellier
Phase 3
220
Montpellier, Bordeaux, Brest, Cahors, La Roche-sur-Yon, Le Mans, Nantes, Nice
2022-11-28
Active, closed
Sanofi
Phase 2
187
Marseille, Nantes, Neuilly-sur-Seine, Vandœuvre-lès-Nancy
2022-11-25
Recruiting
Nantes University Hospital
Not applicable
12
Nantes
2022-11-23
Active, closed
Groupe Francophone des Myelodysplasies
Phase 1/2
55
Angers, Grenoble, Limoges, Montpellier, Nantes, Nice, Paris, Pessac
2022-11-23
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Bron, Créteil, Lille, Marseille, Montpellier, Nantes, Nice, Paris
2022-11-23
Recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
NCT05652335Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis
DrugRamantamig
Janssen Research & Development, LLC
Phase 1
180
Nantes, Pierre-Bénite, Rennes, Toulouse
2022-11-22
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Bordeaux, Caen, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes, Nice
2022-11-21
Recruiting
Centre Hospitalier Intercommunal Creteil
Phase 3
230
Bordeaux, Créteil, Le Kremlin-Bicêtre, Lille, Lyon, Marseille, Nancy, Nantes
2022-11-21
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Strasbourg, Marseille, Dijon, Bordeaux, Nantes, Saint-Étienne-de-Montluc, Lyon, Rouen
2022-11-21
Recruiting
Hopital Foch
Not applicable
480
Bordeaux, Caen, Limoges, Montpellier, Nancy, Nantes, Paris, Reims
2022-11-19
Recruiting
Nantes University Hospital
Observational
30
Nantes
2022-11-15
Recruiting
Pfizer
Phase 3
1,060
Nice, Toulouse, Poitiers, Nantes, Paris, Tours, Villejuif
2022-11-10
Recruiting
University Hospital, Brest
Not applicable
240
Angers, Besançon, Brest, Caen, Grenoble, Nantes, Rennes, Strasbourg
2022-11-08
Recruiting
AfterROSC
Observational
4,500
Nantes, Massy, Neuilly-sur-Seine, Paris, Versailles
2022-11-02
Recruiting
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
NCT05607420B-cell Non-Hodgkin Lymphoma (B-NHL)
DrugAlemtuzumab
Cellectis S.A.
Phase 1/2
80
Pierre-Bénite, Montpellier, Nantes, Paris
2022-11-01
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Créteil, Lille, Lyon, Nantes, Paris, Pessac, Poitiers, Rennes
2022-10-25
Recruiting
Rennes University Hospital
Not applicable
50
Angers, Nantes, Rennes
2022-10-19
Active, closed
Hoffmann-La Roche
Phase 1/2
90
Nantes, Paris, Poitiers
2022-10-17
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Créteil, Dijon, Lyon, Montpellier, Nantes, Nice, Paris, Pessac
2022-10-13
Active, closed
NEAT ID Foundation
Observational
500
Montpellier, Nantes, Nice, Paris
2022-10-10
Active, closed
Genmab
Phase 1
17
Bordeaux, Nantes, Villejuif, Lyon
2022-10-04
Recruiting
PedAL BCU, LLC
Phase 3
130
Toulouse, Loos, Nantes, Lyon, Paris
2022-10-01
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2
105
Besançon, Chalon-sur-Saône, Créteil, Dijon, Montbéliard, Montpellier, Mulhouse, Nantes
2022-09-27
Recruiting
Celgene
Phase 3
810
Pessac, Lyon Cedex08, Lille, Clermont-Ferrand, Limoges, Nantes, Nîmes, Strasbourg
2022-09-20
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Angers, Bordeaux, Clermont-Ferrand, Lille, Lyon, Nantes, Strasbourg
2022-09-19
Active, closed
AstraZeneca
Phase 3
594
Angers, Clamart, Clermont-Ferrand, Créteil, Lyon, Montpellier, Nantes, Paris
2022-09-15
Recruiting
Modifying Factors in Striated Muscle Laminopathies
NCT05394506Laminopathies, Emery Dreifuss Muscular Dystrophy 2, LMNA-Related Congenital Muscular Dystrophy, Dilated Cardiomyopathy-1A
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
40
Bron, Paris, Montpellier, Rennes, Nantes, Rouen, Garches
2022-09-08
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Bordeaux, Lille, Marseille, Montpellier, Nantes, Paris, Poitiers, Toulouse
2022-09-08
Active, closed
Genetics of Ventriculo-arterial Discordance
NCT05330338Heart Defects, Congenital
Nantes University Hospital
Not applicable
600
Marseille, Rennes, Bordeaux, Toulouse, Lille, Le Plessis-Robinson, Nantes, Saint-Herblain
2022-09-07
Active, closed
Dyne Therapeutics
Phase 1/2
127
Nantes, Paris
2022-09-05
Active, closed
Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma
NCT05471843Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma
DrugSonrotoclax
BeOne Medicines
Phase 1/2
125
Le Mans, Nantes, Paris, PierreBenite, Tours
2022-09-05
By invitation
Ottawa Heart Institute Research Corporation
Observational
3,500
Amiens, Créteil, Lille, Lyon, Marseille, Nancy, Nantes, Paris
2022-09-01
Recruiting
Nantes University Hospital
Observational
80
Angers, Brest, Nantes, Paris, Rennes
2022-09-01
Active, closed
UroMems SAS
Not applicable
6
Nantes, Paris
2022-08-31
Recruiting
Asciminib Roll-over Study
NCT04877522Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
DrugsAsciminib single agent·Bosutinib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 4
347
Bordeaux, Lyon, Marseille, Nantes, Paris, Vandœuvre-lès-Nancy
2022-08-30
Active, closed
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
NCT05403385Metastatic NSCLC - Non-Small Cell Lung Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer
DrugsPemetrexed·Carboplatin
iTeos Therapeutics
Phase 2
36
Caen, Marseille, Nantes
2022-08-26
Active, closed
Adverum Biotechnologies, Inc.
Phase 2
69
Nantes, Lyon, Créteil
2022-08-23
Recruiting
Regeneron Pharmaceuticals
Phase 1
317
Poitiers, Lille, Nantes, Angers, Montpellier, Paris, Villejuif, Créteil
2022-08-17
Recruiting
Step Pharma, SAS
Phase 1/2
180
Paris, Lyon, Marseille, Nantes, Villejuif
2022-08-03
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Amiens, Besançon, Créteil, Grenoble, Marseille, Nantes, Neuilly-sur-Seine, Nice
2022-07-22
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
La Roche-sur-Yon, Le Mans, Limoges, Nantes, Nice, Paris, Pierre-Bénite, Rennes
2022-07-22
Active, closed
Gilead Sciences
Phase 3
623
Avignon, Besançon, Brest, Caen, Clermont-Ferrand, Montpellier, Nantes, Pierre-Bénite
2022-07-20
Active, closed
Incyte Corporation
Phase 1/2
53
Grenoble, Nantes, Le Mans, Poitiers
2022-07-19
Active, closed
GlaxoSmithKline
Phase 3
163
La Roche-sur-Yon, Nantes, Paris
2022-07-14
By invitation
Gyroscope Therapeutics Limited
Phase 2
225
Dijon, Nantes
2022-07-12
Active, closed
Genzyme, a Sanofi Company
Phase 4
17
Bordeaux, Brest, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes, Nice
2022-07-11
Not yet open
Weprom
Not applicable
160
Bordeaux, Le Mans, Nantes, Saint-Nazaire, Strasbourg
2022-07-01
Active, closed
Cousin Biotech
Not applicable
196
Lyon, Nantes, Reims, Tourcoing
2022-06-30
Active, closed
Sanofi
Phase 3
531
Nantes, Paris, Poitiers, Saint-Priest-en-Jarez, Toulouse, Tours
2022-06-23
Active, closed
Celgene
Phase 3
939
Argenteuil, La Roche-sur-Yon, Lille, Nancy, Nantes, Paris, Pessac, Rouen
2022-06-23
Recruiting
University Hospital, Brest
Observational
322
Angers, Brest, Caen, Chambéry, Lorient, Nantes, Quimper, Rennes
2022-06-21
Recruiting
Priothera SAS
Phase 3
366
Angers, Lille, Lyon, Nancy, Nantes, Paris, Strasbourg, Toulouse
2022-06-16
Active, closed
Genmab
Phase 2
264
Clermont, Rennes, Vandœuvre-lès-Nancy, Lille, Toulouse, Créteil, Nantes, Pierre-Bénite
2022-06-14
Active, closed
RECORDATI GROUP
Observational
206
Bordeaux, Bron, Grenoble, Le Kremlin-Bicêtre, Lille, Marseille, Nancy, Nantes
2022-06-13
Recruiting
Nuvalent Inc.
Phase 1/2
840
Lyon, Nantes, Toulouse, Villejuif
2022-06-09
Recruiting
University Paul Sabatier of Toulouse
Not applicable
750
Nantes, Toulouse
2022-06-01
Active, closed
Centre Hospitalier Departemental Vendee
Not applicable
50
Créteil, La Roche-sur-Yon, Nantes, Paris
2022-05-31
Active, closed
Janssen Research & Development, LLC
Phase 1
74
Montpellier, Nantes, Poitiers, Toulouse
2022-05-25
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
312
Bordeaux, Dijon, Marseille, Nantes, Paris, Poitiers, Saint-Herblain, Suresnes
2022-05-25
Active, closed
University Hospital, Bordeaux
Phase 1/2
80
Angers, Bordeaux, Lille, Lyon, Marseille, Nantes, Paris, Strasbourg
2022-05-17
Active, closed
European Myeloma Network B.V.
Phase 3
117
Nantes, Paris
2022-04-19
Active, closed
Eli Lilly and Company
Phase 3
925
Lyon, Brest, La Chaussée-Saint-Victor, Dijon, Besançon, Montpellier, Nantes, Saint-Herblain
2022-04-14
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL)
DrugBexobrutideg
Nurix Therapeutics, Inc.
Phase 1
572
Angers, Bobigny, Nantes, Pessac, Poitiers, Saint-Cloud, Vandœuvre-lès-Nancy
2022-04-13
Active, closed
Nantes University Hospital
Phase 3
200
Nantes
2022-04-09
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Grenoble, Nîmes, Nantes, Limoges, Sr Priest En Jarez
2022-04-05
Active, closed
AstraZeneca
Phase 3
760
Angers, Clichy, Créteil, Montpellier, Nantes, Nice, Paris, Strasbourg
2022-03-28
Recruiting
MicroPort CRM
Observational
206
Bordeaux, Le Coudray, Marseille, Nantes, Toulouse, Valence
2022-03-25
Active, closed
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
NCT05477576GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors
DrugsRYZ101·Octreotide·Lanreotide·Sunitinib
RayzeBio, Inc.
Phase 3
343
Clichy, Lille, Montpellier, Nantes, Vandœuvre-lès-Nancy, Villejuif
2022-03-24
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Bordeaux, Grenoble, Clermont-Ferrand, Reims, Nîmes, Mulhouse, Amiens, Nantes
2022-03-15
Active, closed
Eli Lilly and Company
Phase 3
368
Bordeaux, Brest, Nantes, La Roche-sur-Yon
2022-03-11
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
66
Nice, Brest, Nantes, Angers, Marseille, Montpellier
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Avignon, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2022-03-04
Active, closed
Chronic Pain and Hemophilia
NCT05202951Chronic Pain, Hemophilia
University Hospital, Clermont-Ferrand
Observational
350
Bordeaux, Caen, Chambéry, Clermont-Ferrand, Grenoble, Lille, Lyon, Nantes
2022-02-28
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes
DrugsAzoles·Gilteritinib·Azacitidine·Venetoclax
Sumitomo Pharma America, Inc.
Phase 1/2
606
Angers, Bobigny, Le Mans, Lille, Limoges, Lyon, Marseille, Nantes
2022-02-28
Active, closed
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
NCT05204927Metastasis From Malignant Tumor of Prostate
DrugEnzalutamide
Curium US LLC
Phase 3
439
Brest, Clermont-Ferrand, Marseille, Nancy, Nantes, Nîmes, Strasbourg, Toulouse
2022-02-14
Recruiting
Nantes University Hospital
Not applicable
114
Nantes
2022-02-02
Active, closed
Denali Therapeutics Inc.
Phase 1/2
85
Nantes, Rouen, Toulouse
2022-02-01
Recruiting
Nantes University Hospital
Not applicable
130
Nantes
2022-01-24
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Bayonne, Besançon, Colombes, Nantes, Nice, Paris, Pierre-Bénite, Reims
2022-01-19
Recruiting
INS, B Cells and Microbiota
NCT04924712Microbiota, B-lymphocytes, Glomerulosclerosis, T-lymphocytes
Nantes University Hospital
Observational
30
Nantes, La Roche-sur-Yon
2022-01-18
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Nice, Lyon, Dijon, Toulouse, Paris, Nantes, Marseille, Créteil
2022-01-13
Recruiting
Nuvalent Inc.
Phase 1/2
359
Lyon, Nantes, Toulouse, Villejuif
2022-01-04
Recruiting
Nantes University Hospital
Observational
465
Angers, Brest, La Roche-sur-Yon, La Rochelle, Le Mans, Lorient, Nantes, Orléans
2022-01-04
Recruiting
University Hospital, Brest
Observational
100
Angers, Brest, Caen, Le Mans, Nantes, Rennes
2021-12-26
Active, closed
ITM Solucin GmbH
Phase 3
259
Pessac, Nantes, Lyon, Toulouse
2021-12-21
Recruiting
Occlutech International AB
Observational
255
Le Plessis-Robinson, Lille, Nantes
2021-12-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Brest, Caen, Limoges, Saint-Cloud, Rennes, Montpellier, Nantes
2021-12-13
Recruiting
Centre Hospitalier Departemental Vendee
Not applicable
526
Bayonne, La Roche-sur-Yon, Le Puy-en-Velay, Nantes, Orléans, Rennes, Saint-Herblain
2021-12-07
Active, closed
Abivax S.A.
Phase 2
203
Grenoble, Montpellier, Nantes, Neuilly-sur-Seine, Saint-Etienne
2021-12-03
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Pessac, Avignon, Bordeaux, Dijon, Grenoble, Lyon, Nantes, Poitiers
2021-12-02
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Amiens, Caen, Grenoble, Limoges, Nantes, Paris, Poitiers, Toulouse
2021-11-30
Recruiting
Janssen Pharmaceutica N.V., Belgium
Observational
300
Lille, Montpellier, Nantes, Pierre-Bénite, Toulouse
2021-11-18
Active, closed
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291Coronary Artery Disease, Coronary Artery Stenosis
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Not applicable
1,820
Essey-lès-Nancy, La Rochelle, Le Coudray, Nantes, Rouen, St-Malo
2021-11-16
Active, closed
Septodont
Observational
145
Colombes, Lyon, Nantes, Paris, Reims, Toulouse
2021-11-08
Active, closed
Amgen
Phase 3
303
Créteil, Dijon, Le Chesnay, Lille, Marseille, Nantes, Nice, Paris
2021-11-02
Active, closed
AstraZeneca
Phase 3
454
Bordeaux, Dijon, Le Mans, Lyon, Marseille, Nantes, Toulouse, Villejuif
2021-10-28
Active, closed
Hoffmann-La Roche
Phase 3
478
Bayonne, Chambéry, Créteil, Lille, Marseille, Montpellier, Nantes, Nice
2021-10-27
Recruiting
Bayer
Phase 1/2
430
Lyon, Bordeaux, Nantes, Saint-Herblain, Marseille, Paris, Villejuif
2021-10-25
Active, closed
Camurus AB
Phase 3
332
Bordeaux, Chambray-lès-Tours, Dijon, Lille, Lyon, Nantes, Rennes, Strasbourg
2021-10-22
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
168
Angers, Issy-les-Moulineaux, Nantes, Nîmes, Paris, Sèvres, Villejuif
2021-10-20
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Créteil, Lille, Limoges, Lyon, Nantes, Poitiers, Strasbourg, Toulouse
2021-10-14
Recruiting
Centre Hospitalier Universitaire de Nīmes
Phase 3
180
Bordeaux, Le Kremlin-Bicêtre, Lyon, Nantes, Nîmes, Paris, Poitiers, Toulouse
2021-10-10
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Observational
70
Besançon, La Tronche, Nantes, Paris, Poitiers, Toulouse, Tours
2021-10-07
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 2
690
Lyon, Montpellier, Nantes, Nîmes, Paris, Pierre-Bénite
2021-10-07
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Bordeaux, Lyon, Nantes, Paris
2021-10-06
Recruiting
Pfizer
Phase 3
893
Limoges, Lille, Nantes, Paris, Pierre-Bénite, Poitiers, Toulouse
2021-10-04
Recruiting
University Hospital, Brest
Not applicable
700
Brest, Landerneau, Morlaix, Nantes
2021-10-01
Recruiting
University Hospital, Tours
Phase 3
1,494
Angers, Bordeaux, Brest, Clermont-Ferrand, Marseille, Nancy, Nantes, Orléans
2021-09-28
Active, closed
Janssen Research & Development, LLC
Phase 1
166
Nantes, Pessac, Rennes, Toulouse
2021-09-22
Active, closed
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics
Observational
202
Lille, Nice, Nantes
2021-09-21
Active, closed
Nantes University Hospital
Phase 2
45
Bordeaux, Nantes, Paris
2021-09-21
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Le Mans, Montpellier, Morvan, Nantes, Paris, Pierre-Bénite, Politiers, Rennes
2021-09-20
Recruiting
Nantes University Hospital
Observational
600
Nantes, Paris
2021-09-20
Recruiting
BeOne Medicines
Phase 1/2
246
Lille, Nantes, Poitiers
2021-09-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Nice, Dijon, Bordeaux, Toulouse, Rouen, Montpellier, Nantes, Tourcoing
2021-09-15
Active, closed
Il-Yang Pharm. Co., Ltd.
Phase 2
43
Lille, Limoges, Lyon, Nantes, Paris, Poitiers, Rouen
2021-09-09
Recruiting
Weprom
Phase 3
186
Besançon, Le Mans, Nancy, Nantes, Perpignan
2021-09-08
Recruiting
Poitiers University Hospital
Phase 4
160
Angers, Bordeaux, Limoges, Nantes, Périgueux, Poitiers, Tours
2021-09-07
Active, closed
Sophia Genetics SAS
Observational
4,000
Bobigny, Bordeaux, Boulogne-Billancourt, Lyon, Nantes, Paris, Suresnes, Toulon
2021-08-21
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Lille, Nantes, Paris, Poitiers, Toulouse
2021-08-19
Recruiting
Miltenyi Biomedicine GmbH
Phase 2
213
Créteil, Lille, Lyon, Marseille, Nantes, Pessac, Poitiers, Toulouse
2021-08-18
Recruiting
medac GmbH
Phase 3
210
Amiens, Besançon, Grenoble, Lille, Nantes, Nice, Pierre-Bénite, Toulouse
2021-08-16
Active, closed
Tanabe Pharma America, Inc.
Phase 3
286
Bordeaux, Colombes, Nantes, Paris
2021-08-10
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Bordeaux, Caen, Lille, Lyon, Marseille, Nantes, Nice, Paris
2021-08-04
Active, closed
Nantes University Hospital
Observational
226
Nantes
2021-07-28
Active, closed
Novartis Pharmaceuticals
Phase 3
208
Lille, Nantes, Nice, Paris, Toulouse
2021-07-27
Active, closed
University Hospital, Lille
Not applicable
320
Lille, Lyon, Nantes, Orléans, Paris, Poitiers, Vandœuvre-lès-Nancy
2021-07-23
Recruiting
Bristol-Myers Squibb
Phase 3
102
Nantes, Bordeaux, Bron, Marseille, Paris
2021-07-21
Recruiting
Centre Leon Berard
Phase 2
36
Besançon, Bordeaux, Dijon, Lille, Lyon, Marseille, Montpellier, Nantes
2021-07-21
Active, closed
Boston Scientific Corporation
Not applicable
297
Grenoble, Lille, Nantes, Paris
2021-07-20
Active, closed
VectivBio AG
Phase 3
158
Clichy, Lyon, Nantes, Nice, Pessac, Vandœuvre-lès-Nancy
2021-07-13
Recruiting
HighLife SAS
Not applicable
30
Lille, Nantes, Rennes, Toulouse
2021-07-01
Recruiting
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Phase 2
102
Bobigny, Nancy, Nantes, Nice, Paris, Pessac, Périgueux, Saint-Quentin
2021-06-18
Active, closed
Novartis Pharmaceuticals
Phase 3
1,140
Bordeaux, Clermont-Ferrand, Lyon, Montpellier, Nantes, Paris, Strasbourg, Vandœuvre-lès-Nancy
2021-06-09
Recruiting
Centre Francois Baclesse
Phase 2
50
Angers, Besançon, Caen, Clermont-Ferrand, Dijon, Lyon, Marseille, Nantes
2021-06-01
Recruiting
Janssen Research & Development, LLC
Phase 1/2
420
Besançon, Marseille, Nantes, Paris, Pessac, Pierre-Bénite, Strasbourg, Toulouse
2021-05-19
Active, closed
Santen SAS
Not applicable
80
Brest, La Rochefoucauld, Lyon, Nantes, Paris, Le Kremlin-Bicêtre
2021-05-11
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
NCT04614103Metastatic Non Small Cell Lung Cancer
DrugLifileucel
Iovance Biotherapeutics, Inc.
Phase 2
170
Marseille, Nantes, Nice, Pierre-Bénite, Poitiers, Villejuif
2021-05-07
By invitation
Cytokinetics
Phase 2/3
900
Marseille, Montpellier, Nantes, Paris, Pessac, Rennes, Toulouse
2021-05-06
Recruiting
Hospices Civils de Lyon
Not applicable
330
Chambray-lès-Tours, Colombes, Lyon, Nantes, Pessac, Rennes, Rouen
2021-05-03
Active, closed
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
NCT04868877Non-Small Cell Lung Cancer Metastatic, Gastric Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
DrugsBispecific·Tagrisso·Osimertinib
Merus B.V.
Phase 1/2
194
Amiens, Bordeaux, Bron, Créteil, Lille, Marseille, Nantes, Paris
2021-04-28
Active, closed
Hoffmann-La Roche
Phase 3
557
Grenoble, Lille, Marseille, Montpellier, Nantes, Paris, Pessac, Rennes
2021-04-26
Recruiting
GlaxoSmithKline
Phase 2
37
Nantes, Nice
2021-04-16
Active, closed
Incyte Corporation
Phase 3
654
Amiens, Angers, Bordeaux, Dijon, Le Chesnay, Nantes, Paris, Pontoise
2021-04-15
Active, closed
Geron Corporation
Phase 3
327
Pierre-Bénite, Tours, Paris, Nantes, Nice, Le Mans, Brest
2021-04-12
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Bordeaux, Paris, Lille, Vandœuvre-lès-Nancy, Politiers, Rouen, Nantes, Pessac
2021-04-08
Active, closed
PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS
NCT04664465Inflammatory Rheumatism, Polymyalgia Rheumatica, Giant Cell Arteritis, Idiopathic Inflammatory Myopathies
University Hospital, Brest
Observational
300
Angers, Brest, La Roche-sur-Yon, Le Mans, Morlaix, Nantes, Orléans, Poitiers
2021-03-18
Active, closed
Janssen Research & Development, LLC
Phase 1
140
Lyon, Nantes, Pessac, Rennes, Toulouse
2021-03-12
Active, closed
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
NCT04591392Heart Septal Defect, Heart Septal Defects, Atrial, Heart Defects, Congenital, Cardiovascular Abnormalities
atHeart Medical
Not applicable
250
Bordeaux, Lille, Nantes, Paris, Toulouse
2021-03-12
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
62
Bordeaux, Clermont-Ferrand, Créteil, Dijon, Lille, Montpellier, Nantes, Paris
2021-03-10
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
96
Nîmes, Montpellier, Lyon, Nantes, Toulouse, Paris
2021-03-05
Recruiting
Syndax Pharmaceuticals
Phase 2
296
La Tronche, Strasbourg, Toulouse, Amiens, Lille, Nancy, Nantes, Paris
2021-03-04
Recruiting
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
NCT04502394Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
DrugsNavtemadlin·Acalabrutinib
Kartos Therapeutics, Inc.
Phase 1/2
84
Nantes, Rouen, Tours
2021-02-23
Active, closed
Stichting European Myeloma Network
Phase 2
160
Bordeau, Dijon, Nantes, Paris, Strasbourg, Toulouse
2021-02-22
Active, closed
Sellas Life Sciences Group
Phase 3
127
Amiens, Angers, Caen, Grenoble, Nantes, Paris, Pierre-Bénite, Poitiers
2021-02-08
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
277
Toulouse, Nantes, Lyon, Brest, Grenoble, Paris, Rennes, Villejuif
2021-02-02
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Créteil, Lyon, Montpellier, Nantes, Pessac, Toulouse
2021-02-01
Recruiting
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
NCT04248283Urinary Incontinence, Urinary Incontinence,Stress
Uromedica
Not applicable
167
Marseille, Nantes, Paris
2021-01-26
Recruiting
Nantes University Hospital
Phase 1
7
Nantes
2021-01-26
Recruiting
Sanofi
Phase 1/2
258
Lille, Nantes, Paris
2021-01-25
Recruiting
University Hospital, Brest
Not applicable
140
Angers, Brest, Nantes, Paris, Ploemeur
2021-01-12
Active, closed
Galderma R&D
Phase 3
500
Bordeaux, Brest, Nantes, Nice, Paris, Pierre-Bénite, Rouen, Saint-Etienne
2021-01-11
Recruiting
University Hospital, Angers
Observational
90
Angers, Nantes
2021-01-07
Active, closed
Daiichi Sankyo
Phase 3
605
Besançon, Grenoble, Lyon, Marseille, Nantes, Paris, Poitiers, Rennes
2020-12-21
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
548
Lyon, Pierre-Bénite, Dijon, Toulouse, Lille, Bordeaux, Poitiers, Nantes
2020-12-21
Active, closed
Neurocrine Biosciences
Phase 3
182
Angers, Grenoble, Le Kremlin-Bicêtre, Nantes, Paris
2020-12-16
Active, closed
Amgen
Phase 3
135
Clichy, Lille, Marseille, Nantes, Pessac
2020-12-04
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Montpellier, Pessac, Vandœuvre-lès-Nancy, Paris, Nantes, Clermont-Ferrand
2020-11-25
Active, closed
Science Corporation
Not applicable
38
Lyon, Bordeaux, Créteil, Marseille, Nantes, Paris
2020-11-24
Active, closed
AstraZeneca
Phase 3
957
Avignon, Besançon, Brest, Dijon, Lyon, Montpellier, Nantes, Nice
2020-11-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
300
Angers, Caen, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2020-11-11
Active, closed
Pfizer
Phase 3
114
Nantes, Paris
2020-11-05
Active, closed
Safety and Clinical Performance of a Biological Matrix Used in Abdominal Wall Reconstruction
NCT04580511Abdominal Wall Defect, Abdominal Wall Injury, Abdominal Hernia
Meccellis Biotech
Observational
92
Caen, La Rochelle, Montpellier, Nantes
2020-11-04
Active, closed
Hoffmann-La Roche
Phase 3
985
Bordeaux, Bron, Montpellier, Nantes, Nice, Strasbourg
2020-10-26
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bordeaux, Bron, Dijon, Le Mans, Lille, Nantes, Paris, Pessac
2020-10-13
Recruiting
Intact Cord Resuscitation in CDH
NCT04429750Rare Diseases, Congenital Diaphragmatic Hernia
University Hospital, Lille
Not applicable
180
Amiens, Lille, Nantes
2020-10-08
Active, closed
Acerta Pharma BV
Phase 3
611
Brest, Caen, Marseille, Montpellier, Nantes, Pessac, Pierre-Bénite, Rennes
2020-10-08
Active, closed
University Hospital, Brest
Not applicable
70
Angers, Bordeaux, Grenoble, Lyon, Nantes, Paris, Rennes, Roscoff
2020-10-02
Active, closed
CARdiomyopathy in Type 2 DIAbetes Mellitus
NCT04303364Cardiomyopathy, Diabetic
Institut National de la Santé Et de la Recherche Médicale, France
Observational
1,256
Bron, Créteil, Grenoble, Marseille, Nantes, Paris
2020-10-02
Recruiting
University Hospital, Toulouse
Phase 2
32
Grenoble, Lille, Marseille, Montpellier, Nantes, Poitiers, Toulouse
2020-09-22
Active, closed
argenx
Phase 2
229
Angers, Bordeaux, Clermont-Ferrand, Le Kremlin-Bicêtre, Limoges, Nantes, Nice, Paris
2020-09-18
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Lille, Lyon, Nantes, Poitiers, Toulouse, Tours
2020-09-17
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Brest, Bobigny, Dijon, Nantes, Paris, Pessac, Rouen
2020-09-16
Active, closed
AbbVie
Phase 3
531
Nice, Pessac, La Tronche, Lille, Nantes, Marseille, Rouen, Avignon
2020-09-10
Active, closed
PREdiction of Chronic LUng Allograft Dysfunction
NCT03967340Lung Transplant Rejection
Nantes University Hospital
Observational
240
Bordeaux, Grenoble, Le Plessis-Robinson, Lyon, Marseille, Nantes, Paris, Strasbourg
2020-09-10
Active, closed
AbbVie
Phase 3
330
Nice, Nîmes, Pessac, Nantes, Pierre-Bénite, Chambéry, Angers, Paris
2020-08-31
Recruiting
Centre Georges Francois Leclerc
Phase 2
7,976
Amiens, Besançon, Bordeaux, Caen, Dijon, Levallois-Perret, Lille, Nantes
2020-08-25
Recruiting
Takeda
Phase 2
210
Angers, Épagny, Nantes, Nice, Paris, Pontoise, Talence
2020-08-19
Recruiting
Eisai Inc.
Phase 1/2
182
Nice, Strasbourg, Marseille, Caen, Saint-Brieuc, Nantes, Lille, Bayonne
2020-08-06
Recruiting
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
NCT05040373Hereditary Transthyretin-mediated (hATTR) Amyloidosis, Polyneuropathy
Alnylam Pharmaceuticals
Observational
10
Nantes
2020-08-01
Active, closed
Medtronic
Observational
2,200
Avignon, Metz-Tessy, Nantes, Saint-Priest-en-Jarez, Brest, Caen, Clermont-Ferrand, Dijon
2020-08-01
Active, closed
Medtronic
Observational
2,200
Avignon, Brest, Caen, Clermont-Ferrand, Dijon, La Rochelle, Nantes, Pringy
2020-08-01
Recruiting
Institut Cancerologie de l'Ouest
Observational
300
Angers, La Roche-sur-Yon, Lyon, Montpellier, Nantes, Nice, Saint-Cloud, Suresnes
2020-07-10
Recruiting
Nantes University Hospital
Phase 3
110
Angers, Brest, Limoges, Nantes, Rennes, Tours
2020-06-19
Recruiting
Rennes University Hospital
Observational
3,200
Angers, Brest, Chartres, Le Mans, Lorient, Nantes, Poitiers, Quimperlé
2020-06-15
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Lille, Lyon, Montpellier, Nantes, Paris, Poitiers, Toulouse
2020-06-12
Active, closed
Epizyme, Inc.
Phase 3
599
Pessac, Brest, Bordeaux, Mulhouse, Rouen, Limoges, La Tronche, Nantes
2020-06-11
Recruiting
Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic
NCT04389463Patients Undergoing Cardiac or Thoracic Surgery
Nantes University Hospital
Observational
350
Nantes
2020-05-11
Active, closed
Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)
NCT04184050Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma of Bone, Multiple Myeloma With Failed Remission
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1
100
Nantes, Poitiers
2020-04-13
Active, closed
Nantes University Hospital
Phase 3
42
Angers, Clermont-Ferrand, Clichy, Créteil, Lille, Lyon, Nancy, Nantes
2020-03-12
Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
NCT04094610Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors
DrugRepotrectinib
Turning Point Therapeutics, Inc.
Phase 1/2
75
Lyon, Angers, Bordeaux, Marseille, Nantes, Paris, Villejuif
2020-03-12
Active, closed
First-in-Human Study of ICT01 in Patients With Advanced Cancer
NCT04243499Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
ImCheck Therapeutics, an Ipsen company
Phase 1/2
293
Bordeaux, Lyon, Marseille, Nantes, Nice, Paris, Poitiers
2020-03-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Dijon, Montpellier, Rennes, Nantes, Paris
2020-02-27
Recruiting
Nantes University Hospital
Phase 1
6
Nantes
2020-02-09
Recruiting
Nantes University Hospital
Phase 2
25
Bordeaux, Lyon, Nantes, Rennes
2020-02-06
Recruiting
Nantes University Hospital
Not applicable
278
Brest, Colombes, La Roche-sur-Yon, Nantes
2020-02-03
Recruiting
Poitiers University Hospital
Observational
6,000
Angoulême, Argenteuil, Béthune, Chartres, Lille, Montpellier, Nantes, Poitiers
2020-01-09
Active, closed
Advanced Accelerator Applications
Phase 3
226
Clichy, Lyon, Montpellier, Nantes, Villejuif
2020-01-08
Active, closed
The Netherlands Cancer Institute
Phase 3
538
Besançon, Bordeaux, Lille, Lyon, Montpellier, Nantes, Paris, Strasbourg
2020-01-01
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Brest, Caen, Le Kremlin-Bicêtre, Nantes, Rennes, Saint-Priest-en-Jarez
2019-11-13
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Pessac, Caen, Pierre-Bénite, Lille, Nantes, Poitiers, Paris, Créteil
2019-11-13
Active, closed
Rennes University Hospital
Not applicable
37
Angers, Brest, Nantes, Poitiers, Rennes, Saint-Avé, St-Malo, Tours
2019-11-08
Active, closed
Janssen Research & Development, LLC
Phase 2
208
Lille, Nantes, Paris
2019-11-07
Active, closed
AstraZeneca
Phase 3
140
Dijon, Marseille, Montpellier, Nantes, Paris, Suresnes, Toulouse
2019-10-29
Active, closed
Bristol-Myers Squibb
Phase 3
790
Brest, Besançon, Bordeaux, Lille, Marseille, Nantes, Nice, Paris
2019-10-28
Recruiting
GlaxoSmithKline
Phase 1/2
184
Bordeaux, Lille, Marseille, Montpellier, Nantes, Paris, Toulouse
2019-10-25
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
32
Besançon, Créteil, Levallois-Perret, Lille, Lyon, Montpellier, Nantes, Paris
2019-10-23
Recruiting
Cellectis S.A.
Phase 1/2
52
Nantes, Paris, Pierre-Bénite, Rennes
2019-10-14
Active, closed
Celgene
Phase 1/2
424
Lille, Marseille, Nantes, Toulouse, Tours
2019-09-30
Active, closed
NeuroDerm Ltd.
Phase 3
381
Bron, Clermont-Ferrand, Nantes, Nice, Nîmes, Toulouse
2019-09-30
Active, closed
Applied Therapeutics, Inc.
Phase 3
675
Bondy, Créteil, Nantes, Valenciennes
2019-09-20
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
DrugsTulmimetostat·Enzalutamide
Novartis Pharmaceuticals
Phase 1/2
300
Bordeaux, Lille, Lyon, Nantes, Saint-Herblain, Strasbourg, Villejuif
2019-09-18
Active, closed
MedImmune LLC
Phase 1/2
61
Nantes, Villejuif
2019-09-13
Active, closed
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
NCT04067336Advanced Malignant Neoplasm, Acute Myeloid Leukemia, Mixed Lineage Leukemia, Mixed Lineage Acute Leukemia
DrugsZiftomenib·Itraconazole·Midazolam
Kura Oncology, Inc.
Phase 1/2
263
Lille, Nantes, Paris, Pessac, Pierre-Bénite, Villejuif
2019-09-12
Active, closed
PDC*line Pharma SAS
Phase 1/2
73
Grenoble, Lyon, Nantes
2019-09-10
Active, closed
Pfizer
Phase 3
896
Amiens, Grenoble, Montpellier, Nantes, Nice, Toulouse
2019-09-05
Active, closed
BeOne Medicines
Phase 3
510
Bordeaux, Brest, Dijon, Grenoble, Le Mans, Lille, Marseille, Nantes
2019-08-20
Recruiting
Unruptured Cerebral Aneurysm: Prediction of Evolution
NCT04578808Unruptured Intracranial Aneurysm
Nantes University Hospital
Observational
1,000
Marseille, Brest, Bordeaux, Toulouse, Limoges, Rennes, Tours, Nantes
2019-08-19
Active, closed
Sanofi
Observational
1,860
Argenteuil, Bordeaux, Lille, Marseille, Martigues, Nantes, Paris, Toulouse
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Amiens, Brest, Dijon, La Tronche, Nantes, Poitiers
2019-08-15
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Bordeaux, Clermont-Ferrand, Nancy, Nantes, Nîmes, Strasbourg
2019-08-12
Active, closed
Bristol-Myers Squibb
Phase 3
839
Limoges, Lille, Bayonne, Besançon, Lyon, Marseille, Montpellier, Nantes
2019-08-05
Active, closed
Nantes University Hospital
Phase 2
50
Nantes, Caen, Dijon, Grenoble, La Roche-sur-Yon, Lille, Lyon, Pessac
2019-07-30
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Angers, Besançon, Bordeaux, Créteil, Lyon, Nantes, Paris, Quint-Fonsegrives
2019-06-11
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Dijon, Bordeaux, Boulogne-Billancourt, La Tronche, Lille, Lyon, Nantes, Nice
2019-06-04
Recruiting
HighLife SAS
Not applicable
120
Toulouse, Lille, Lyon, Massy, Nantes, Paris, Pessac, Rennes
2019-05-28
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Marseille, Nantes, Rennes, Tours
2019-04-26
Recruiting
Nantes University Hospital
Observational
2,720
Nantes
2019-03-28
Active, closed
Eisai Inc.
Phase 3
1,906
Marseille, Montpellier, Nantes, Paris, Toulouse, Bron, Strasbourg
2019-03-27
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Besançon, Lille, Nantes, Nice, Paris, Pessac, Poitiers, Strasbourg
2019-03-22
Active, closed
AstraZeneca
Phase 3
724
Bron, Dijon, Lyon, Nantes, Pierre-Bénite, Toulouse, Villejuif
2019-03-06
Active, closed
University Hospital, Montpellier
Phase 2/3
113
Montpellier, Nantes, Paris
2019-02-18
Recruiting
MYeloma Resistance And Clonal Evolution
NCT03807128Multiple Myeloma
Nantes University Hospital
Observational
1,400
La Roche-sur-Yon, Nantes
2019-02-11
Recruiting
University Hospital, Tours
Observational
150
Bordeaux, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Rennes
2019-02-04
Active, closed
AstraZeneca
Phase 2
367
Dijon, Marseille, Nantes, Paris, Rennes
2019-01-09
Active, closed
AstraZeneca
Phase 3
1,407
Besançon, Bordeaux, Limoges, Lyon, Marseille, Nantes, Paris, Saint-Herblain
2019-01-04
Active, closed
Celgene
Phase 3
363
Angers, Bayonne, Caen, La Tronche, Le Mans, Lille, Limoges, Nantes
2019-01-02
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Lille, Montpellier, Nantes, Nice, Nîmes, Paris, Strasbourg
2018-12-28
Active, closed
Stichting European Myeloma Network
Phase 3
709
Nantes
2018-12-14
Active, closed
AbbVie
Phase 3
265
La Tronche, Reims, Vandœuvre-lès-Nancy, Lille, Créteil, Nantes, Pierre-Bénite, Rouen
2018-10-22
Active, closed
French Innovative Leukemia Organisation
Phase 2
110
Angers, Bayonne, Clermont-Ferrand, Grenoble, Marseille, Montpellier, Mulhouse, Nantes
2018-10-11
Recruiting
Nantes University Hospital
Observational
200
Nantes
2018-09-23
Active, closed
AbbVie
Phase 3
1,242
Nice, Marseille, Montpellier, Vandœuvre-lès-Nancy, Pessac, Saint Priest EN Jarez, Amiens, Nantes
2018-08-28
Recruiting
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
NCT03583710ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma
DrugsMitotane·Cis-platinum·CDDP·Etoposide
M.D. Anderson Cancer Center
Phase 3
240
Angers, Besançon, Brest, Dijon, Lyon, Marseille, Nantes, Paris
2018-08-20
Recruiting
Celgene
Phase 2/3
1,541
Creteil-Paris, Lille, Lyon, Marseille, Montpellier, Nantes, Paris, Pessac
2018-07-19
Active, closed
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck
DrugsTisotumab Vedotin·Tivdak·Keytruda·Cisplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
350
Besançon, Bourgoin, Lyon, Marseille, Nantes, Pont-de-Vaux, Portes-lès-Valence, Suresnes
2018-06-25
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Observational
150
Villejuif, Créteil, Lille, Lyon, Marseille, Montpellier, Nantes, Nice
2018-06-22
Recruiting
University Hospital, Brest
Phase 3
62
Brest, Flavigny-sur-Moselle, Nantes, Nîmes, Rennes, Saint-Etienne, Saint-Maurice
2018-05-17
Active, closed
AbbVie
Phase 2
156
Limoges, Tours, Nantes, Villejuif, Poitiers, Paris
2018-04-02
Recruiting
Octapharma
Observational
200
Besançon, Chambéry, Chambray-lès-Tours, Le Mans, Montmorency, Nantes, Paris, Saint-Priest-en-Jarez
2018-02-13
Recruiting
Dabrafenib and/or Trametinib Rollover Study
NCT03340506Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
100
Lyon, Nantes, Paris, Villejuif
2018-01-26
Active, closed
AstraZeneca
Phase 2
528
Bordeaux, Nantes, Paris, Villejuif
2017-12-18
Active, closed
Sanofi
Phase 3
475
Bayonne, Caen, Dijon, La Roche-sur-Yon, Lille, Nantes, Paris, Pessac
2017-12-07
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
57
Avignon, Besançon, Créteil, Levallois-Perret, Lyon, Nantes, Paris, Poitiers
2017-12-04
Recruiting
Centre Hospitalier Universitaire de la Réunion
Not applicable
75
Bordeaux, Limoges, Nantes, Rennes, Saint-Denis
2017-11-28
Active, closed
BeiGene
Phase 3
590
Argenteuil, Bordeaux, Caen, La Roche-sur-Yon, Le Mans, Limoges, Marseille, Nantes
2017-10-31
Recruiting
Italfarmaco
Phase 2/3
206
Nantes, Paris
2017-10-24
Recruiting
Montreal Heart Institute
Not applicable
250
Nantes
2017-10-15
Active, closed
Genzyme, a Sanofi Company
Phase 2
22
Nantes, Paris, Tours
2017-10-12
Active, closed
AstraZeneca
Phase 3
1,324
Clichy, Lille, Marseille, Montpellier, Nancy, Nantes, Nice, Pessac
2017-10-11
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Amiens, Arras, Bayonne, Beuvry, Grenoble, Lyon, Nantes, Paris
2017-09-25
Active, closed
Hoffmann-La Roche
Phase 3
382
Besançon, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Pierre-Bénite
2017-09-20
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bordeaux, Bron, Lille, Montpellier, Nantes, Paris, Toulouse
2017-09-12
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
1,200
Bordeaux, Caen, Limoges, Nancy, Nantes, Paris, Rennes, Suresnes
2017-07-13
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Pessac, Tours, Nantes, Pierre-Bénite, Le Mans, Brest, Caen, Grenoble
2017-06-26
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Nantes, Rouen, Saint-Brieuc
2017-05-22
Active, closed
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776Triple-Negative Breast Neoplasm
UNICANCER
Not applicable
149
Clermont-Ferrand, Dijon, Lyon, Marseille, Nantes, Rennes, Strasbourg, Vandœuvre-lès-Nancy
2017-04-14
Active, closed
Acerta Pharma BV
Phase 3
310
Bordeaux, Brest, Montpellier, Nantes, Paris, Perpignan, Provence Alpes Cote D'Azur, Rennes
2017-02-02
Active, closed
ITM Solucin GmbH
Phase 3
324
Bron, Clermont-Ferrand, Clichy, Montpellier, Nantes, Toulouse
2017-02-02
Active, closed
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
NCT03305146Pancreatic Cyst, Pancreas Cyst, Serous Cystadenoma, Mucinous Cystadenoma
Hospital St. Joseph, Marseille, France
Not applicable
93
Charenton-le-Pont, Limoges, Lyon, Marseille, Nantes, Nice, Paris, Vichy
2017-01
Recruiting
Second STOP After Pioglitazone Priming in CML Patients
NCT02889003Chronic Myeloid Leukemia (CML)
DrugPioglitazone
Versailles Hospital
Phase 2
26
Le Chesnay, Le Kremlin-Bicêtre, Lyon, Nantes, Rennes, Toulouse
2016-12
Recruiting
French Cardiology Society
Observational
500
Lyon, Nantes, Paris
2016-10
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Villejuif, Angers, Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2016-08-03
Active, closed
Philogen S.p.A.
Phase 3
214
Marseille, Nantes, Villejuif
2016-07-01
Active, closed
Nantes University Hospital
Not applicable
72
Angers, Brest, Marseille, Nantes, Rennes
2016-07
Recruiting
Institut Bergonié
Not applicable
205
Bordeaux, Dijon, Lille, Lyon, Marseille, Nantes, Paris, Toulouse
2016-06
Recruiting
Cohort Primary Hyperparathyroidism
NCT05469087Primary Hyperparathyroidism
Nantes University Hospital
Observational
403
Nantes
2016-03-31
Active, closed
AstraZeneca
Phase 1/2
264
Bordeaux, Caen, Clermont-Ferrand, Dijon, Marseille, Nantes, Paris, Pierre Benit Cedex
2016-03-17
Active, closed
Women at Risk of Breast Cancer and OLFM4
NCT02653105Hereditary Breast and Ovarian Cancer Syndrome
Institut Cancerologie de l'Ouest
Not applicable
150
Angers, Brest, Nantes, Vannes
2016-03-08
Active, closed
MedImmune LLC
Phase 1/2
383
Marseille, Nantes
2016-02-22
Active, closed
Nantes University Hospital
Not applicable
435
Nantes
2016-01-07
Active, closed
Institut Cancerologie de l'Ouest
Not applicable
769
Nantes, Saint-Herblain, Villejuif
2016-01
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Nantes, Paris, Pessac, Pierre-Bénite, Strasbourg, Villejuif
2015-11-02
Recruiting
University Hospital, Geneva
Observational
20,000
Nantes
2015-06-01
Active, closed
ViiV Healthcare
Phase 3
371
Bordeaux, Marseille, Nantes, Paris
2015-02-23
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Angers, Brest, La Roche-sur-Yon, Lille, Montpellier, Nantes, Paris, Saint-Grégoire
2014-12-17
Active, closed
Acerta Pharma BV
Phase 2
107
Aurillac, Clermond Ferrand, Marseille, Montpellier, Nantes, Paris, Pierre-Bénite, Poitiers
2014-09-11
Active, closed
Institut Cancerologie de l'Ouest
Phase 2
102
Nantes
2014-02
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Bordeaux, Caen, Lyon, Nantes, Paris, Pierre-Bénite, Saint-Cloud, Toulouse
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Bordeaux, Caen, Lyon, Nantes, Paris, Vandœuvre-lès-Nancy, Villejuif
2013-08-26
Recruiting
Post Traumatic Critical Complications: a Prospective Cohort Study (ATLANREA)
NCT02426255Severe Trauma (With or Without Traumatic Brain Injury)
Nantes University Hospital
Observational
5,000
Angers, Nantes, Poitiers, Rennes, Tours
2013-03-29
Recruiting
Nantes University Hospital
Observational
5,000
Angers, Brest, Nantes, Poitiers, Rennes, Tours
2013-02
Active, closed
Bristol-Myers Squibb
Observational
2,555
Blois, Chalon-sur-Saône, La Roche-sur-Yon, Limoges, Meaux, Nantes, Rennes
2012-06-13
Recruiting
Patient Retrospective Outcomes (PRO)
NCT01550575Chronic Pain
Boston Scientific Corporation
Observational
15,000
Caen, Créteil, Lyon, Nantes, Paris, Poitiers, Saint-Herblain, Suresnes
2012-04-03
Recruiting
Nantes University Hospital
Observational
16,000
Nantes
2012-03-01
Recruiting
Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
NCT06911099Atrial Functional Mitral Regurgitation, Mitral Insufficiency
University Hospital of Cologne
Observational
1,000
Bordeaux, Nantes
2010-01-01
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
40
Nice, Lille, Marseille, Nantes, Nîmes, Paris, Poitiers, Rennes
2010-01-01
Rows per page Showing 501–906 of 906
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 October 2026. https://priyalifescience.com/clinical-trials-france/city/nantes?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 906 of those studies with a site in Nantes.

How many clinical trials are recruiting in Nantes?

523 of the 906 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 77 have not yet opened recruitment, 294 are active but closed to new participants, and 12 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.